{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:15:42Z","timestamp":1791281742483,"version":"4.1.0"},"reference-count":29,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["#P30 AG059301"],"award-info":[{"award-number":["#P30 AG059301"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["#RP210130"],"award-info":[{"award-number":["#RP210130"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to investigate the association of testosterone replacement therapy (TTh) with risk of cardiovascular disease (CVD), and CVD-specific outcomes, in cisgender women and transgender population, and to determine whether this association varies by menopausal status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In 25 796 cisgender women and 1580 transgender people (\u226530 years old) who were enrolled in the Optum's deidentified Clinformatics Data Mart Database (2007-2021), we identified 6288 pre- and postmenopausal cisgender women and 262 transgender people diagnosed with incident composite of CVD (coronary artery disease [CAD], congestive heart failure, stroke, and myocardial infarction). Prediagnostic prescription of TTh was ascertained for this analysis. Multivariable adjusted Cox proportional hazards models were used to examine the independent association of TTh with incident CVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found a 24% increased risk of CVD (hazard ratio [HR] = 1.24; 95% CI, 1.15-1.34), 26% risk of CAD (HR = 1.26; 95% CI, 1.14-1.39), and a 29% risk of stroke (HR = 1.29; 95% CI, 1.14-1.45) after comparing cisgender women who used TTh with nonusers. Stratification by age group showed similar effects of TTh on CVD, CAD, and stroke. Among transgender people, TTh did not increase the risk of composite CVD, including by age stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Use of TTh increased the risk of CVD, CAD, and stroke among cisgender women but not among transgender people. TTh is becoming more widely accepted in women, and it is the main medical treatment for transgender males. Therefore, use of TTh should be further investigated for the prevention of CVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad388","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T15:39:05Z","timestamp":1688225945000},"page":"e1515-e1523","source":"Crossref","is-referenced-by-count":18,"title":["Testosterone Replacement Therapy in Relation With Cardiovascular Disease in Cisgender Women and Transgender People"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-0372","authenticated-orcid":false,"given":"David S","family":"Lopez","sequence":"first","affiliation":[{"name":"School of Public and Population Health, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juwairia S","family":"Mulla","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"El Haddad","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Ibrahim","family":"Tahashilder","sequence":"additional","affiliation":[{"name":"School of Public and Population Health, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathia","family":"Polychronopolou","sequence":"additional","affiliation":[{"name":"School of Public and Population Health, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Baillargeon","sequence":"additional","affiliation":[{"name":"School of Public and Population Health, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1927-0927","authenticated-orcid":false,"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[{"name":"School of Public and Population Health, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Gilani","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam I","family":"Khalife","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine, University of Texas Medical Branch , Galveston, TX 77555-0553 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"issue":"9","key":"2023111712371876100_dgad388-B1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jsxm.2018.06.012","article-title":"Endogenous testosterone levels and cardiovascular risk: meta-analysis of observational studies","volume":"15","author":"Corona","year":"2018","journal-title":"J Sex Med"},{"issue":"5","key":"2023111712371876100_dgad388-B2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2015.12.005","article-title":"Testosterone and cardiovascular disease","volume":"67","author":"Kloner","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2023111712371876100_dgad388-B3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.21037\/tau.2016.10.02","article-title":"Testosterone replacement therapy and the heart: friend, foe or bystander?","volume":"5","author":"Lopez","year":"2016","journal-title":"Transl Androl Urol"},{"issue":"3","key":"2023111712371876100_dgad388-B4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5534\/wjmh.2015.33.3.130","article-title":"Testosterone replacement therapy and cardiovascular risk: a review","volume":"33","author":"Corona","year":"2015","journal-title":"World J Mens Health"},{"issue":"1","key":"2023111712371876100_dgad388-B5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-11-108","article-title":"Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med"},{"issue":"12","key":"2023111712371876100_dgad388-B6","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S2213-8587(15)00284-3","article-title":"Testosterone in women\u2013the clinical significance","volume":"3","author":"Davis","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2023111712371876100_dgad388-B7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/nau.24622","article-title":"Testosterone supplementation and the gender divide","volume":"40","author":"Donovitz","year":"2021","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"2023111712371876100_dgad388-B8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","article-title":"Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data","volume":"7","author":"Islam","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2023111712371876100_dgad388-B9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","article-title":"Testosterone therapy for transgender men","volume":"5","author":"Irwig","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2023111712371876100_dgad388-B10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11154-018-9454-3","article-title":"Cardiovascular health in transgender people","volume":"19","author":"Irwig","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"2023111712371876100_dgad388-B11","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s11606-019-05365-0","article-title":"Testosterone prescribing among women in the USA, 2002-2017","volume":"35","author":"Baillargeon","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"10","key":"2023111712371876100_dgad388-B12","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2023111712371876100_dgad388-B13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1377\/hlthaff.2021.00546","article-title":"Privately insured transgender people are at elevated risk for chronic conditions compared with cisgender counterparts","volume":"40","author":"Hughes","year":"2021","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"2023111712371876100_dgad388-B14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S2213-8587(21)00185-6","article-title":"Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam Cohort of Gender Dysphoria","volume":"9","author":"de Blok","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023111712371876100_dgad388-B15","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211051546","article-title":"Effects of testosterone treatment on transgender males: a single-institution study","author":"Korpaisarn","year":"2021","journal-title":"SAGE Open Med"},{"issue":"7","key":"2023111712371876100_dgad388-B16","doi-asserted-by":"crossref","first-page":"P832","DOI":"10.4158\/EP151185.OR","article-title":"Transgender care by endocrinologists in the United States","volume":"22","author":"Irwig","year":"2016","journal-title":"Endocr Pract"},{"issue":"11","key":"2023111712371876100_dgad388-B17","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"2023111712371876100_dgad388-B18","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","journal-title":"J Sex Med"},{"issue":"4","key":"2023111712371876100_dgad388-B19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2023111712371876100_dgad388-B20","author":"Lopez"},{"key":"2023111712371876100_dgad388-B21","author":"MCHP SAS macros. University of Manitoba"},{"issue":"1","key":"2023111712371876100_dgad388-B22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1210\/jcem.86.1.7103","article-title":"Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen","volume":"86","author":"Worboys","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023111712371876100_dgad388-B23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.mca.0000236290.79306.d1","article-title":"Endogenous testosterone and endothelial function in postmenopausal women","volume":"18","author":"Montalcini","year":"2007","journal-title":"Coron Artery Dis"},{"issue":"4","key":"2023111712371876100_dgad388-B24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-10-0307","article-title":"Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients","volume":"163","author":"Sievers","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023111712371876100_dgad388-B25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.atherosclerosis.2012.09.014","article-title":"The relationship between sex hormones, sex hormone binding globulin and peripheral artery disease in older persons","volume":"225","author":"Maggio","year":"2012","journal-title":"Atherosclerosis"},{"issue":"11","key":"2023111712371876100_dgad388-B26","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023111712371876100_dgad388-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","article-title":"Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses","volume":"72","author":"Elamin","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023111712371876100_dgad388-B28","doi-asserted-by":"crossref","first-page":"3-IV-18","DOI":"10.1097\/00005650-200208001-00002","article-title":"Overview of the SEER-medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"issue":"2","key":"2023111712371876100_dgad388-B29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/aje\/155.2.176","article-title":"Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology","volume":"155","author":"Hernan","year":"2002","journal-title":"Am J Epidemiol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad388\/50881753\/dgad388.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/12\/e1515\/53480885\/dgad388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/12\/e1515\/53480885\/dgad388.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T08:38:11Z","timestamp":1700210291000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/12\/e1515\/7216817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,7,1]]},"published-print":{"date-parts":[[2023,11,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad388","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,7,1]]}}}